Drug intelligence / Profile preview

KGS Tablet

Development stage
Preclinical
Lead developer
Arya Vaidya Sala Kottakkal
Modality
Small Molecules
Administration
Oral
01

Overview

KGS Tablet is an Ayurvedic herbal formulation developed by Kottakkal Arya Vaidya Sala, primarily derived from the plant *Cyanthillium cinereum* (commonly known as Sahadevi or *Vernonia cinerea*). It is formulated as an oral tablet and is utilized for its reported anti-inflammatory and anticancer properties. Research conducted by the developer focuses on phytochemical analysis and observational studies rather than conventional Phase 1-3 clinical trials. The therapeutic effects are attributed to the natural bioactive compounds present in the herbal extract, which have shown activity in preliminary studies against inflammatory conditions and various cancer cell lines. As a traditional medicine, it is part of the company's research and development pipeline aimed at validating traditional Ayurvedic treatments through modern scientific methods.

Brand names
KGS Tablet
Other names
Cyanthillium cinereum-based formulationSahadevi-based formulationVernonia cinerea-based formulation

Beyond the preview

Go deeper on KGS Tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KGS Tablet.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call